Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided botulinum toxin injection for adductor laryngeal dystonia
RBR-33x3vp3Recruiting
- Sponsor
- Hospital de Clínicas da Universidade Federal do Paraná
- Start
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of botulinum toxin type A in Adductor laryngeal dystonia (AdLD) and laryngeal dystonia (SD) (2 arms), sponsored by Hospital de Clínicas da Universidade Federal do Paraná. Started Feb 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Adductor laryngeal dystonia (AdLD)laryngeal dystonia (SD)
Beyond the preview
Go deeper on RBR-33x3vp3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-33x3vp3.